PDX Model Market

1. Executive Summary
    1.1. Key Market Insights  

2. Introduction            
    2.1. Study Objectives        
    2.2. Market Definition        
           2.2.1. Market Covered    
           2.2.2. Regional Coverage    
           2.2.3. Study Years & Currency    
    2.3. Market Stakeholders        
    2.4. Key Questions this Study will Answer        
    2.5. GMI Research’s Approach & Methodology  
           2.5.1. Research Data
           2.5.2. Primary Data
           2.5.3. Demand Side and Supply Side Analysis
           2.5.4. Market Size Estimation
           2.5.5. Research Assumptions

3. Global PDX Model Market- Overview            
    3.1. Introduction         
    3.2. Market Segmentation        
    3.3. Value Chain Analysis        
    3.4. Market Drivers        
    3.5. Market Restraints        
    3.6. Market Trends      

4. Global PDX Model Market Revenue Forecast till 2028     

5. Global PDX Model Market by Type Revenue Forecast till 2028            
    5.1. Mice Models 
    5.2. Rat Models

6. Global PDX Model Market by Tumor type Revenue Forecast till 2028            
    6.1. Gastrointestinal Tumor Models
    6.2. Gynecological Tumor Models
    6.3. Respiratory Tumor Models
    6.4. Urological Tumor Models
    6.5. Hematological Tumor Models 
    6.6. Others

7. Global PDX Model Market by Application Revenue Forecast till 2028            
    7.1. Preclinical Drug Development
    7.2. Biomarker Analysis 
    7.3. Basic Cancer Research

8. Global PDX Model Market by End-user Revenue Forecast till 2028            
    8.1. Pharmaceutical & Biotechnology Companies
    8.2. Contract Research Organizations (CROs)
    8.3. Academic & Research Institutions Commercial

9. Global PDX Model Market by Region Forecast till 2028
    9.1. North America PDX Model Market Revenue Forecast till 2028 
    (Option 1: As a part of the free 25% customization)
           9.1.1. North America PDX Model Market by Type
                     9.1.1.1. Mice Models 
                     9.1.1.2. Rat Models
           9.1.2. North America PDX Model Market by Tumor type
                     9.1.2.1. Gastrointestinal Tumor Models
                     9.1.2.2. Gynecological Tumor Models
                     9.1.2.3. Respiratory Tumor Models
                     9.1.2.4. Urological Tumor Models
                     9.1.2.5. Hematological Tumor Models 
                     9.1.2.6. Others
           9.1.3. North America PDX Model Market by Application
                     9.1.3.1. Preclinical Drug Development
                     9.1.3.2. Biomarker Analysis 
                     9.1.3.3. Basic Cancer Research
           9.1.4. North America PDX Model Market by End-user
                     9.1.4.1. Pharmaceutical & Biotechnology Companies
                     9.1.4.2. Contract Research Organizations (CROs)
                     9.1.4.3. Academic & Research Institutions Commercial
           9.1.5. US PDX Model Market All-Up
           9.1.6. Canada PDX Model Market All-Up
    9.2. Europe PDX Model Market Revenue Forecast till 2028 
    (Option 2: As a part of the free 25% customization)
           9.2.1. Europe PDX Model Market by Type
                     9.2.1.1. Mice Models 
                     9.2.1.2. Rat Models
           9.2.2. Europe PDX Model Market by Tumor type
                     9.2.2.1. Gastrointestinal Tumor Models
                     9.2.2.2. Gynecological Tumor Models
                     9.2.2.3. Respiratory Tumor Models
                     9.2.2.4. Urological Tumor Models
                     9.2.2.5. Hematological Tumor Models 
                     9.2.2.6. Others
           9.2.3. Europe PDX Model Market by Application
                     9.2.3.1. Preclinical Drug Development
                     9.2.3.2. Biomarker Analysis 
                     9.2.3.3. Basic Cancer Research
           9.2.4. Europe PDX Model Market by End-user
                     9.2.4.1. Pharmaceutical & Biotechnology Companies
                     9.2.4.2. Contract Research Organizations (CROs)
                     9.2.4.3. Academic & Research Institutions Commercial
           9.2.5. UK PDX Model Market All-Up
           9.2.6. Germany PDX Model Market All-Up
           9.2.7. France PDX Model Market All-Up
           9.2.8. Spain PDX Model Market All-Up
           9.2.9. Rest of Europe PDX Model Market All-Up
    9.3. Asia-Pacific PDX Model Market Revenue Forecast till 2028 
    (Option 3: As a part of the free 25% customization) 
           9.3.1. Asia-Pacific PDX Model Market by Type
                     9.3.1.1. Mice Models 
                     9.3.1.2. Rat Models
           9.3.2. Asia-Pacific PDX Model Market by Tumor type
                     9.3.2.1. Gastrointestinal Tumor Models
                     9.3.2.2. Gynecological Tumor Models
                     9.3.2.3. Respiratory Tumor Models
                     9.3.2.4. Urological Tumor Models
                     9.3.2.5. Hematological Tumor Models 
                     9.3.2.6. Others
           9.3.3. Asia-Pacific PDX Model Market by Application
                     9.3.3.1. Preclinical Drug Development
                     9.3.3.2. Biomarker Analysis 
                     9.3.3.3. Basic Cancer Research
           9.3.4. Asia-Pacific PDX Model Market by End-user
                     9.3.4.1. Pharmaceutical & Biotechnology Companies
                     9.3.4.2. Contract Research Organizations (CROs)
                     9.3.4.3. Academic & Research Institutions Commercial
           9.3.5. China PDX Model Market All-Up
           9.3.6. India PDX Model Market All-Up
           9.3.7. Japan PDX Model Market All-Up
           9.3.8. Rest of APAC PDX Model Market All-Up
    9.4. RoW PDX Model Market Revenue Forecast till 2028
    (Option 4: As a part of the free 25% customization)  
           9.4.1. RoW PDX Model Market by Type
                     9.4.1.1. Mice Models 
                     9.4.1.2. Rat Models
           9.4.2. RoW PDX Model Market by Tumor type
                     9.4.2.1. Gastrointestinal Tumor Models
                     9.4.2.2. Gynecological Tumor Models
                     9.4.2.3. Respiratory Tumor Models
                     9.4.2.4. Urological Tumor Models
                     9.4.2.5. Hematological Tumor Models 
                     9.4.2.6. Others
           9.4.3. RoW PDX Model Market by Application
                     9.4.3.1. Preclinical Drug Development
                     9.4.3.2. Biomarker Analysis 
                     9.4.3.3. Basic Cancer Research
           9.4.4. RoW PDX Model Market by End-user
                     9.4.4.1. Pharmaceutical & Biotechnology Companies
                     9.4.4.2. Contract Research Organizations (CROs)
                     9.4.4.3. Academic & Research Institutions Commercial
           9.4.5. Brazil PDX Model Market All-Up
           9.4.6. South Africa PDX Model Market All-Up
           9.4.7. Saudi Arabia PDX Model Market All-Up
           9.4.8. UAE PDX Model Market All-Up
           9.4.9. Rest of world (remaining countries of the LAMEA region) PDX Model Market All-Up

10. Competitive Landscape Analysis
    10.1. Porter’s Five Forces Analysis
    10.2. Industry – Competitive Landscape
    10.3. Market Presence (Intensity Mapping)
    10.4. Key Strategic Market Developments 

11. Company Profiles (Option 5: Free 25% Customization - Profiles of 5 Additional Companies of your Choice)
    11.1. JSR Corporation.
           11.1.1. Company Overview    
           11.1.2. Key Executives 
           11.1.3. Footprint & Employee Strength 
           11.1.4. Product Offerings    
           11.1.5. Financials
           11.1.6. Key Company Developments 
    11.2. WuXi AppTec
           11.2.1. Company Overview    
           11.2.2. Key Executives   
           11.2.3. Footprint & Employee Strength
           11.2.4. Product Offerings
           11.2.5. Financials
           11.2.6. Key Company Developments
    11.3. THE JACKSON LABORATORY
           11.3.1. Company Overview    
           11.3.2. Key Executives
           11.3.3. Footprint & Employee Strength
           11.3.4. Product Offerings
           11.3.5. Financials
           11.3.6. Key Company Developments
    11.4. Charles River Laboratories.
           11.4.1. Company Overview    
           11.4.2. Key Executives
           11.4.3. Footprint & Employee Strength
           11.4.4. Product Offerings
           11.4.5. Financials
           11.4.6. Key Company Developments
    11.5. Oncodesign
           11.5.1. Company Overview    
           11.5.2. Key Executives   
           11.5.3. Footprint & Employee Strength
           11.5.4. Product Offerings
           11.5.5. Financials
           11.5.6. Key Company Developments
    11.6. Envigo
           11.6.1. Company Overview    
           11.6.2. Key Executives
           11.6.3. Footprint & Employee Strength
           11.6.4. Product Offerings
           11.6.5. Financials
           11.6.6. Key Company Developments
    11.7. Pharmatest Services
           11.7.1. Company Overview
           11.7.2. Key Executives
           11.7.3. Footprint & Employee Strength
           11.7.4. Product Offerings
           11.7.5. Financials
           11.7.6. Key Company Developments    
    11.8. Hera Biolabs.
           11.8.1. Company Overview
           11.8.2. Key Executives 
           11.8.3. Footprint & Employee Strength
           11.8.4. Product Offerings
           11.8.5. Financials
           11.8.6. Key Company Developments    
    11.9. EPO Berlin-Buch GmbH
           11.9.1. Company Overview
           11.9.2. Key Executives 
           11.9.3. Footprint & Employee Strength
           11.9.4. Product Offerings
           11.9.5. Financials
           11.9.6. Key Company Developments   
    11.10. Xentech
           11.10.1. Company Overview
           11.10.2. Key Executives 
           11.10.3. Footprint & Employee Strength
           11.10.4. Product Offerings
           11.10.5. Financials
           11.10.6. Key Company Developments   

12. About GMI Research

*Details on Financials might not be available in case of unlisted/private companies.

*The list of companies is based on preliminary research in this sample report, the companies in the final report may change based on research findings.